Skip to Content

Notice

Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice; establishment of a public docket; request for comments; correction.

SUMMARY:

The Food and Drug Administration is correcting a notice entitled “Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments” that appeared in the Federal Register of February 22, 2018. The document was published with the incorrect docket number. This document corrects that error.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In the Federal Register of Thursday, February 22, 2018 (83 FR 7727), in FR Doc. 2018-03603, on page 7727, the following correction is made:

1. On page 7727, in the first column, in the header of the document, the docket number is corrected to read “FDA-2018-N-0410.”

Start Signature

Dated: March 5, 2018.

Leslie Kux,

Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2018-04774 Filed 3-8-18; 8:45 am]

BILLING CODE 4164-01-P